ArticleBJC reports2023

Radiomics and outcome prediction to antiangiogenic treatment in advanced gastroenteropancreatic neuroendocrine tumours: findings from the phase II TALENT trial.

Marta Ligero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.